Nyxoah SA

5.09+0.08 (+1.7%)

Oct 29, 4:00:00 PM EDT · NasdaqGM · NYXH · USD

Upcoming Earnings

Report date

Nov 13, 2025 (in 14 days)

Key Stats

Market Cap

204.28M

P/E (TTM)

Basic EPS (TTM)

-2.46

Dividend Yield

About

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

CEO

Mr. Robert Taub MBA

IPO

4/28/2021

Website

https://www.nyxoah.com

Employees

183

Sector

Healthcare

Industry

Medical Instruments & Supplies